RFK Jr. proposes FDA look the other way on unproven peptides, report says
Summary
Under Health Secretary Robert F. Kennedy Jr., the Food and Drug Administration is planning to loosen regulations on certain unproven peptide drugs. This shift is advancing despite warnings from agency scientists who argue these treatments lack sufficient safety data and could potentially harm consumers.
Under Health Secretary Robert F. Kennedy Jr., the Food and Drug Administration is moving forward with plans to ease access to unproven peptide drugs that are popular among members of Kennedy's Make America Healthy Again movement—despite FDA staff scientists finding that the drugs have not been sufficiently studied to establish safety and efficacy and may cause harms. The FDA submitted…
Source: Read the full story at Ars Technica - All content